Generated by AI
Outset Medical, Inc. is a medical technology company focused on dialysis care. Its core product, the Tablo Hemodialysis System, is designed to simplify hemodialysis by combining integrated water purification, on-demand dialysate production, software, and connectivity in a compact platform. The company also provides related consumables and a data ecosystem that includes tools for healthcare providers, patients, and internal analytics. Outset Medical serves hospitals, dialysis clinics, and home-care settings, supporting dialysis delivery across the continuum of care. The company’s products are positioned to help healthcare providers manage dialysis programs with a more streamlined and technology-enabled workflow. Headquartered in San Jose, California, Outset Medical operates in the renal care and medical equipment markets, where it offers a specialized solution for patients and providers involved in kidney replacement therapy.
Website3052 Orchard Drive
San Jose, CA, 95134
United States
The latest articles about OM.
Outset Medical Inc (OM) posted $33.6 million in Q3 2026 revenue with console sales up 26% year-over-year, 40.8% non-GAAP gross margin, and a $150 million console refresh opportunity ahead.
Summary of Feb 12's posts. Generated by AI.
Summary of Jan 12's posts. Generated by AI.
Summary of Jan 12's posts. Generated by AI.
Investors talking about OM also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.